Literature DB >> 33164138

Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US".

Richard Manning1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 33164138     DOI： 10.1007/s40273-020-00975-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  A model of effective health policy: the 1983 Orphan Drug Act.

Authors:  Natalie D Reaves
Journal:  J Health Soc Policy       Date:  2003

2.  Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US.

Authors:  William V Padula; Sonal Parasrampuria; Mariana P Socal; Rena M Conti; Gerard F Anderson
Journal:  Pharmacoeconomics       Date:  2020-10       Impact factor: 4.981
  2 in total
  1 in total

1.  Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US".

Authors:  William V Padula; Sonal Parasrampuria; Mariana P Socal; Rena M Conti; Gerard F Anderson
Journal:  Pharmacoeconomics       Date:  2020-11-09       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.